Table: Zeria Pharm - 9-MTH group results

Zeria Pharmaceutical

05/02/2026 07:00

Feb 5 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             64.08               64.77            90.00    
                 (-1.1 pct)          (+11.8 pct)      (+3.1 pct)  
  Operating          8.57               10.25            12.00    
                 (-16.4 pct)         (+8.0 pct)       (-1.6 pct)  
  Recurring          7.29               10.66            12.00    
                 (-31.7 pct)         (+12.9 pct)      (-6.5 pct)  
  Net                5.55                8.23             9.50    
                 (-32.5 pct)         (-2.3 pct)       (-4.4 pct)  
  EPS            126.00 yen          186.63 yen       215.52 yen  
  Ann Div                             47.00 yen        48.00 yen  
  -Q2 div         24.00 yen           23.00 yen                   
  -Q4 div                             24.00 yen        24.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T